Prostate cancer: towards the standardization and synthesis of morphology, genetics, and prognosis.
Prostate cancer research and diagnosis is undergoing a revolution in our understanding of the disease process and standardization of diagnostic criteria. Although great progress has been made, there remain many areas of uncertainty and debate. The revolution towards a synthesis of pathology with genetic changes and prognostic models is only just beginning. This supplement presents the opinions and findings of leading international experts in histopathology and prostate research dealing with subjects ranging from aetiology, basic anatomy and morphology to prognostic models, genetic changes and new drug treatments. We hope that this exciting and rapidly changing field will capture the imagination of both experienced and trainee pathologists to advance the field in both research and diagnosis.
Department of Medical Oncology, Barts Cancer Centre, Barts and London School of Medicine and Dentistry, London, UK. D.berney@bartsandthelondon.nhs.uk
Dan
D
Berney
Liang
L
Cheng
D014408:Biomarkers, Tumor / Q000235:genetics; D006801:Humans; D008297:Male; D011379:Prognosis; D011467:Prostate / Q000473:pathology*; D017430:Prostate-Specific Antigen / Q000235:genetics; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000235:genetics* / Q000473:pathology; D012015:Reference Standards
D014408:Biomarkers, Tumor; D017430:Prostate-Specific Antigen